Lutnick discusses drug prices in meeting with Eli Lilly CEO
ReutersMar 10, 2026 9:09 PM
March 10 (Reuters) - U.S. Commerce Secretary Howard Lutnick met with Eli Lilly CEO David Ricks on Tuesday to discuss the Trump administration's "most-favored nation" deals to reduce prescription drug prices, the U.S. Commerce Department said in a statement.
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
CRCL Beyond $100: Decoding the Forces Behind Circle’s 100% Rally and the Quest for $300
Circle leads crypto stocks, surging 107% over the past month to $110 and entering a critical zone.TradingKey
15 hours ago
Micron vs. Samsung vs. SK Hynix: Is MU Stock the Best Memory Stock for 2026?
TradingKey - Relying on strong AI demand, more memory per system, and sluggish supply response, 2026 will be the memory cycle. Micron Technology (MU) is now in an excellent competitive position today with HBM3E and looking to ramp HBM4E into Nvidia’s Vera Rubin platforms in the second half of 2026.TradingKey
16 hours ago
Oracle Earnings Preview: Warner Bros is Becoming Central to Oracle's Future
How is the WBD Deal Affecting ORCL Stock?TradingKey
20 hours ago
